Liu Cao

2.1k total citations · 1 hit paper
33 papers, 1.4k citations indexed

About

Liu Cao is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Liu Cao has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 12 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Liu Cao's work include SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (6 papers) and interferon and immune responses (5 papers). Liu Cao is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (6 papers) and interferon and immune responses (5 papers). Liu Cao collaborates with scholars based in China, United States and Canada. Liu Cao's co-authors include Yu Chen, Mǎng Shī, Ke Lan, Yu Zhou, Yingle Liu, Yong Xiong, Dong Guo, Dehe Wang, Yuan Liu and Ming Guo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Liu Cao

31 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

2020 782 citations Yong Xiong, Yuan Liu et al. Emerging Microbes & Infections profile →

Peers

Countries citing papers authored by Liu Cao

Since Specialization

Citations

This map shows the geographic impact of Liu Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liu Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liu Cao more than expected).

Fields of papers citing papers by Liu Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liu Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liu Cao. The network helps show where Liu Cao may publish in the future.

Co-authorship network of co-authors of Liu Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Liu Cao. A scholar is included among the top collaborators of Liu Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liu Cao. Liu Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses 2025 ·Acta Pharmaceutica Sinica B ·(unknown), Kun Li, (unknown), Konstantin I. Ivanov, Sidi Yang, Yanxi Ji, (unknown), Wenbin Wu, (unknown), (unknown), Feng Cong, Qifan Zhou, Yingjun Li, Ji‐An Pan, Jincun Zhao, Chunmei Li, Xumu Zhang, Liu Cao, Deyin Guo	1
2	Rapid and accurate detection of infectious SARS-CoV-2 by viral receptor capture combined with loop-mediated isothermal amplification 2025 ·Virologica Sinica ·(unknown), Xinrong Zhou, (unknown), Liu Cao, (unknown), Kun Li, Hongchao Liu, Yanxi Ji, Lihong Liu, Konstantin I. Ivanov, Zhijian Yang, Deyin Guo, Chunmei Li	1
3	Whole-cell response of coronavirus-infected BMDCs through proteomic and transcriptomic analyses 2025 ·Frontiers in Immunology ·Yanxi Ji, (unknown), Yongjia Tong, Liu Cao, (unknown), (unknown), (unknown), (unknown), Zhidong Tang, Zhen Zhang, Lin Guo, Deyin Guo, Huabin Zhao, Yu Chen, Xiaolu Zhao	0
4	Reconstitution of RNA cap methylation reveals different features of SARS‐CoV‐2 and SARS‐CoV methyltransferases 2024 ·Journal of Medical Virology ·Miao He, Liu Cao, Lihong Liu, (unknown), (unknown), Xue Liu, (unknown), (unknown), (unknown), Yanxi Ji, (unknown), SI-YAO HUANG, (unknown), (unknown), Kun Li, Panpan Hou, Ji‐An Pan, Deyin Guo, Chunmei Li	0
5	Synthesis of deuterated S-217622 (Ensitrelvir) with antiviral activity against coronaviruses including SARS-CoV-2 2023 ·Antiviral Research ·(unknown), Liu Cao, (unknown), Jun Zhou, Sidi Yang, (unknown), SI-YAO HUANG, Kun Li, Qifan Zhou, Guanguan Li, Yujun Zhu, Cong Feng, Hongmin Zhang, Deyin Guo, Yingjun Li, Xumu Zhang	14
6	SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis 2023 ·Redox Biology ·Lihong Liu, Jie Du, Sidi Yang, (unknown), Jian Shen, Jiacheng Huang, Liu Cao, (unknown), Xue Liu, Liping Guo, Chunmei Li, Changwen Ke, Xiaofang Peng, Deyin Guo, Hong Peng	30
7	Comparison of model‐specific histopathology in mouse models of COVID‐19 2022 ·Journal of Medical Virology ·Sidi Yang, Liu Cao, (unknown), (unknown), (unknown), Yanxi Ji, (unknown), Lihong Liu, Jie Du, Hong Peng, Huan Zhang, Jingdiao Chen, Bixia Ke, Huanying Zheng, Xiaoling Deng, Chunmei Li, Deyin Guo	10
8	ILF3 represses repeat-derived microRNAs targeting RIG-I mediated type I interferon response 2022 ·Journal of Molecular Biology ·Geng Chen, Yang Yang, Qijia Wu, Liu Cao, (unknown), Changwei Shao, (unknown), Peng Tang, (unknown), Ao Jiang, Zhen Wang, Kai Wu, Qiangfeng Cliff Zhang, Xiang‐Dong Fu, Yu Zhou	3
9	Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2 2022 ·Frontiers in Cellular and Infection Microbiology ·Weijie Zeng, Fan Xing, Yanxi Ji, Sidi Yang, (unknown), (unknown), Chunmei Li, Junyu Wu, Liu Cao, Deyin Guo	4
10	A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery 2021 ·Virologica Sinica ·Yunyun Jin, (unknown), Liu Cao, Wei-Chen Wu, Yanxi Ji, (unknown), Yiling Jiang, (unknown), (unknown), Fan Xing, (unknown), Mǎng Shī, Ji‐An Pan, Xiaoxue Peng, Deyin Guo	29
11	Autophagy receptor CCDC50 tunes the STING-mediated interferon response in viral infections and autoimmune diseases 2021 ·Cellular and Molecular Immunology ·Panpan Hou, Yuxin Lin, Zibo Li, Ruiqing Lu, Yicheng Wang, Tian Tian, Penghui Jia, Xi Zhang, Liu Cao, Zhong‐Wei Zhou, Chunmei Li, Jieruo Gu, Deyin Guo	39
12	Genome-wide analysis of protein–protein interactions and involvement of viral proteins in SARS-CoV-2 replication 2021 ·Cell & Bioscience ·Yiling Jiang, (unknown), (unknown), (unknown), (unknown), (unknown), Yunyun Jin, Liu Cao, (unknown), Xing‐Ding Zhang, Deyin Guo, Ji‐An Pan, Xiaoxue Peng	22
13	Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication 2021 ·Redox Biology ·(unknown), (unknown), Kai Zheng, (unknown), (unknown), Ting Yu, Liu Cao, Qianqian Shao, Yong Zou, Wei Xia, Qianglin Fang, Bo Zhao, Deyin Guo, Xiaoxue Peng, Ji‐An Pan	12
14	Endogenous reverse transcriptase and RNase H-mediated antiviral mechanism in embryonic stem cells 2021 ·Cell Research ·Junyu Wu, Chunyan Wu, Fan Xing, Liu Cao, Weijie Zeng, Liping Guo, Ping Li, (unknown), (unknown), (unknown), Guang Shi, Lang Bu, Yanxi Ji, Panpan Hou, Hong Peng, Junjiu Huang, Chunmei Li, Deyin Guo	13
15	Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients breakdown → 2020 ·Emerging Microbes & Infections ·Yong Xiong, Yuan Liu, Liu Cao, Dehe Wang, Ming Guo, Ao Jiang, Dong Guo, Wenjia Hu, Jiayi Yang, Zhidong Tang, Honglong Wu, Yongquan Lin, (unknown), Zhang Qi, Mǎng Shī, Yingle Liu, Yu Zhou, Ke Lan, Yu Chen	782
16	P200 family protein IFI204 negatively regulates type I interferon responses by targeting IRF7 in nucleus 2019 ·PLoS Pathogens ·Liu Cao, Yanxi Ji, (unknown), Qianyun Liu, Zhen Zhang, (unknown), (unknown), Yongjia Tong, Xiaolu Zhao, Chunmei Li, Yu Chen, Deyin Guo	27
17	Immune regulator ABIN1 suppresses HIV-1 transcription by negatively regulating the ubiquitination of Tat 2017 ·Retrovirology ·Shiyou Chen, Xiaodan Yang, (unknown), (unknown), Yafang Shang, Liu Cao, Shuliang Chen, Yu Chen, Min Wang, Deyin Guo	15
18	NF-κB-DICER-miRs Axis Regulates TNF-α Expression in Responses to Endotoxin Stress 2015 ·International Journal of Biological Sciences ·Yi Guan, Hailan Yao, Junfeng Wang, Kailai Sun, Liu Cao, Yizheng Wang	12
19	P68 RNA helicase as a molecular target for cancer therapy 2014 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Liu Cao, Zichen Yang, Yashu Li, Li Tan, Xinze Ran, Chunmeng Shi	38
20	Cellular Stress Induced Alterations in MicroRNA let-7a and let-7b Expression Are Dependent on p53 2011 ·PLoS ONE ·Anthony D. Saleh, Jason E. Savage, Liu Cao, Benjamin P. Soule, David Ly, William DeGraff, Curtis C. Harris, James B. Mitchell, Nicole L. Simone	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact